Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
57.05
-1.00 (-1.72%)
Aug 14, 2025, 9:14 AM - Market open
Company Description
Hinge Health, Inc. develops health care software for joint and muscle health.
The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation.
It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.
Hinge Health, Inc.
| Country | United States |
| Founded | 2012 |
| IPO Date | May 22, 2025 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,437 |
| CEO | Daniel Perez |
Contact Details
Address: 455 Market Street, Suite 700 San Francisco, California 94105 United States | |
| Phone | 415 726 2206 |
| Website | hingehealth.com |
Stock Details
| Ticker Symbol | HNGE |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $32.00 |
| CIK Code | 0001673743 |
| ISIN Number | US4333131039 |
| Employer ID | 81-1884841 |
| SIC Code | 7374 |
Key Executives
| Name | Position |
|---|---|
| Daniel A. Perez | Co-Founder, Chief Executive Officer and Director |
| Gabriel Mecklenburg | Co-Founder and Executive Chairman |
| James Pursley | President |
| James W. Budge | Chief Financial Officer |
| Alexander Annison | Chief Operating Officer |
| Lalith Vadlamannati | Chief Technology Officer |
| David Wood | Secretary and Vice President of Legal |
| Darren Skolnick | Director of Compliance |
| Erin Wilson | Senior Vice President of Sales and Strategy |
| Dr. Jeffrey Krauss M.D. | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 13, 2025 | SCHEDULE 13G | Filing |
| Aug 13, 2025 | SCHEDULE 13G | Filing |
| Aug 13, 2025 | 8-K | Current Report |
| Aug 13, 2025 | SCHEDULE 13G | Filing |
| Aug 11, 2025 | 10-Q | Quarterly Report |
| Aug 5, 2025 | 8-K | Current Report |
| Jul 30, 2025 | SCHEDULE 13G | Filing |
| May 23, 2025 | 8-K | Current Report |
| May 23, 2025 | 424B4 | Prospectus |
| May 22, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |